Summary by Moomoo AI
Vertex Pharmaceuticals Inc. officer Ourania Tatsis is set to sell 360 common shares of the company on 02/21/2024, as per the latest filing. The shares, valued at an aggregate market value of $151,837.20, were acquired on 02/20/2024 as performance shares, a form of compensation from the issuer. This transaction follows a recent history of sales by Tatsis, who sold 794 shares over the past three months, generating total gross proceeds of $333,934.56. The planned sale is in line with a notice dated 02/21/2024, with the plan adopted on 05/09/2023.